Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Building on our long-standing presence in Canada and well-established market access, we remain committed to expanding access to innovative, high-quality, and affordable GLP-1 treatments for individuals living with diabetes
North America retains a leading position, while Asia Pacific is projected to grow rapidly due to expanding patient populations and improved healthcare investment
These outcomes are substantially greater than what sitagliptin alone can deliver
However, the sustainability of this growth trajectory faces challenges, particularly regarding payer willingness to cover lifelong medication expenses
US$ 24.63
US$ 21.23
US$ 25.89
US$ 25.42
